Cargando…

A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study

BACKGROUND: A 2:1 (150 IU:75 IU) follitropin alfa:lutropin alfa formulation has been developed. A 3-year post-marketing surveillance study is ongoing in Germany to explore the use of this formulation in routine clinical practice. MATERIALS AND METHODS: An 11-month interim analysis of data from assis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bühler, Klaus, Naether, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167469/
https://www.ncbi.nlm.nih.gov/pubmed/20849209
http://dx.doi.org/10.3109/09513590.2010.511014